ISLAND PHARMACEUTICALS LTD
Clinical trial NCT07529704 updates: 1. completion date: 2028-06-01 → 2028-09-01 2. primary completion date: 2028-04-01 → 2028-06-01 3. collaborators added: Gerencia de Atención Primaria de Burgos, Instituto de Investigación Biosanitaria de Burgos (IBioBurgos), Universidad de Burgos
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical